<DOC>
	<DOCNO>NCT01682837</DOCNO>
	<brief_summary>Liquid potassium-magnesium citrate ( KMgCit ) pharmaceutical formulation lower blood pressure among patient pre- Stage I hypertension customary diet .</brief_summary>
	<brief_title>Value Liquid Potassium Magnesium Citrate Controlling Hypertension</brief_title>
	<detailed_description>In protocol , investigator want explore whether KMgCit take customary dietary setting , might serve `` surrogate '' DASH diet low blood pressure . This study obvious biomedical importance . Lifestyle modification often recommend pre- Stage I hypertension . The DASH diet modification show effective . However , diet costly difficult adhere long-term . If KMgCit show effective lower blood pressure , would provide safe convenient alternative DASH diet .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Potassium Citrate</mesh_term>
	<mesh_term>Magnesium citrate</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Men woman &gt; 21 year age Any Race/Ethnicity Pre Stage I hypertension ( BP &gt; = 120/80 &lt; = 159/99 ) Diabetes mellitus Renal impairment ( serum creatinine &gt; 1.4 mg/dL ) Any heart diseases congestive heart failure sustain arrhythmia Chronic NSAID use Treatment diuretic Gastroesophageal reflux disease ( GERD ) require treatment acid reduce agent antacid week Esophagealgastric ulcer Chronic diarrhea Hyperkalemia ( serum &gt; 4.6 mEq/L patient ACE inhibitor ARBs , serum K &gt; 5.0 patient ACE inhibitor ARBs ) Abnormal liver function test ( AST ALT upper limit normal range ) Subjects require potassium supplement regular basis reason Pregnancy History major depression , bipolar disorder , schizophrenia</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>